Relief from within: a peptide therapy for fibrosis.
A modified, natural peptide derived from the antiangiogenic molecule endostatin has the potential to become a breakthrough therapy for organ fibrosis (Yamaguchi et al., this issue).
University of Maryland School of Medicine, Baltimore, MD 21201, USA. satamas@umaryland.edu
Sergei P
SP
Atamas
D020533:Angiogenesis Inhibitors / Q000737:chemistry* / Q000627:therapeutic use*; D000818:Animals; D043169:Endostatins / Q000737:chemistry*; D005355:Fibrosis / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism; D006801:Humans; D010455:Peptides / Q000737:chemistry* / Q000627:therapeutic use*
D020533:Angiogenesis Inhibitors; D043169:Endostatins; D010455:Peptides